Business Context and Reporting Period
Company: Disc Medicine, Inc. (Nasdaq: IRON)
Filing Type: Form 8-K (Current Report)
Date of Report: May 15, 2023
Reporting Period: Quarter ended March 31, 2023
Context: The Company announced its financial results for the quarter and provided a corporate update. The detailed results are contained in a press release furnished as Exhibit 99.1.
Key Financial Metrics
The provided Form 8-K text serves as a cover document referencing the announcement of financial results but does not contain specific numerical data. The filing text does not provide clear values for:
- Revenue
- Profit or Net Loss
- Cash Flow
- Operating Margins
- Debt Levels
- Liquidity Position
Material Changes
The filing text does not provide specific data to compare current period performance against the prior comparable period. Investors must refer to the attached press release (Exhibit 99.1) for details on material changes.
Guidance, Outlook, and Risks
Management Commentary: The Company provided a corporate update alongside the financial results, though specific commentary is not included in this text.
Guidance and Outlook: No specific forward-looking guidance or outlook figures are present in the filing text.
Risks and Contingencies: No specific risks or contingencies are detailed in this excerpt. The filing notes that the information is furnished and not "filed" for purposes of Section 18 of the Exchange Act, limiting liability.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for actual revenue, net loss, and cash burn figures for the quarter ended March 31, 2023.
- Verify the Company's cash runway and liquidity position as disclosed in the full press release.
- Confirm any updates to the corporate strategy or pipeline mentioned in the "corporate update."
- Check for any new debt financing or equity raises announced in the full disclosure.